Evaluation of drug-targetable genes by defining modes of abnormality in gene expression.
about
Germinal-center kinase-like kinase co-crystal structure reveals a swapped activation loop and C-terminal extensionRegulation of bioenergetics through dual inhibition of aldehyde dehydrogenase and mitochondrial complex I suppresses glioblastoma tumorspheres.Oncopression: gene expression compendium for cancer with matched normal tissues.Potential prognostic biomarkers identified by DNA methylation profiling analysis for patients with lung adenocarcinoma.A Computational Method for Classifying Different Human Tissues with Quantitatively Tissue-Specific Expressed GenesAstragalus polysaccharide combined with 10-hydroxycamptothecin inhibits metastasis in non-small cell lung carcinoma cell lines via the MAP4K3/mTOR signaling pathway
P2860
Evaluation of drug-targetable genes by defining modes of abnormality in gene expression.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Evaluation of drug-targetable genes by defining modes of abnormality in gene expression.
@ast
Evaluation of drug-targetable genes by defining modes of abnormality in gene expression.
@en
type
label
Evaluation of drug-targetable genes by defining modes of abnormality in gene expression.
@ast
Evaluation of drug-targetable genes by defining modes of abnormality in gene expression.
@en
prefLabel
Evaluation of drug-targetable genes by defining modes of abnormality in gene expression.
@ast
Evaluation of drug-targetable genes by defining modes of abnormality in gene expression.
@en
P2860
P356
P1433
P1476
Evaluation of drug-targetable genes by defining modes of abnormality in gene expression
@en
P2093
Chulhee Choi
Junseong Park
P2860
P2888
P356
10.1038/SREP13576
P407
P50
P577
2015-09-04T00:00:00Z